EI
TMDX icon

EAM Investors’s Transmedics TMDX Stock Holding History

EAM Investors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,642
Closed -$4.65M – 352
2024
Q3 		$4.65M Sell
29,642
-4,804
-14% -$740K 0.7% 41
2024
Q2 		$5.19M Buy
+34,446
New +$4.13M 0.84% 11
2023
Q3 		– Sell
-42,081
Closed -$3.53M – 377
2023
Q2 		$3.53M Sell
42,081
-6,165
-13% -$472K 0.65% 26
2023
Q1 		$3.65M Sell
48,246
-9,698
-17% -$671K 0.72% 16
2022
Q4 		$3.58M Sell
57,944
-19,367
-25% -$1.03M 0.74% 15
2022
Q3 		$3.23M Sell
77,311
-21,862
-22% -$951K 0.7% 21
2022
Q2 		$3.12M Buy
+99,173
New +$2.64M 0.76% 15

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM Investors's TMDX Position: Q4 2024 in Review

EAM Investors sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 29,642 shares — an estimated $4.65M sold.

EAM Investors first reported a position in TMDX in Q2 2022 and held it in 7 quarters. The position peaked at $5.19M in Q2 2024. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • EAM Investors reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • EAM Investors sold 29,642 Transmedics shares in Q4 2024, an estimated $4.65M.
  • EAM Investors first reported a position in Transmedics in Q2 2022 and held it in 7 quarters.
  • EAM Investors's Transmedics position peaked at $5.19M in Q2 2024.
  • 315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on EAM Investors's 13F filing for Q4 2024, filed 13 Feb 2025.